As of 2026-09-12, the EV/EBITDA ratio of Precision BioSciences Inc (DTIL) is -2.68. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DTIL's latest enterprise value is 121.33 mil USD. DTIL's TTM EBITDA according to its financial statements is -45.35 mil USD. Dividing these 2 quantities gives us the above DTIL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.4x - 16.0x | 15.8x |
| Forward P/E multiples | 16.0x - 19.1x | 17.5x |
| Fair Price | (25.62) - (25.73) | (26.80) |
| Upside | -457.3% - -458.8% | -473.8% |
| Date | EV/EBITDA |
| 2026-09-09 | -2.72 |
| 2026-09-08 | -2.81 |
| 2026-09-04 | -2.85 |
| 2026-09-03 | -2.79 |
| 2026-09-02 | -2.83 |
| 2026-09-01 | -2.94 |
| 2026-08-31 | -2.94 |
| 2026-08-28 | -3.02 |
| 2026-08-27 | -3.38 |
| 2026-08-26 | -3.43 |
| 2026-08-25 | -3.46 |
| 2026-08-24 | -3.40 |
| 2026-08-21 | -3.63 |
| 2026-08-20 | -3.56 |
| 2026-08-19 | -3.43 |
| 2026-08-18 | -3.28 |
| 2026-08-17 | -2.81 |
| 2026-08-14 | -2.82 |
| 2026-08-13 | -2.75 |
| 2026-08-12 | -2.82 |
| 2026-08-11 | -2.87 |
| 2026-08-10 | -2.84 |
| 2026-08-07 | -2.86 |
| 2026-08-06 | -2.82 |
| 2026-08-05 | -2.85 |
| 2026-08-04 | -2.74 |
| 2026-08-03 | -2.61 |
| 2026-07-31 | -2.57 |
| 2026-07-30 | -2.58 |
| 2026-07-29 | -2.52 |
| 2026-07-28 | -2.68 |
| 2026-07-27 | -2.72 |
| 2026-07-24 | -2.74 |
| 2026-07-23 | -2.77 |
| 2026-07-22 | -2.76 |
| 2026-07-21 | -2.93 |
| 2026-07-20 | -2.78 |
| 2026-07-17 | -3.07 |
| 2026-07-16 | -3.33 |
| 2026-07-15 | -3.61 |
| 2026-07-14 | -3.48 |
| 2026-07-13 | -3.48 |
| 2026-07-10 | -3.58 |
| 2026-07-09 | -3.81 |
| 2026-07-08 | -3.88 |
| 2026-07-07 | -3.86 |
| 2026-07-06 | -3.28 |
| 2026-07-02 | -3.25 |
| 2026-07-01 | -3.08 |
| 2026-06-30 | -3.07 |